-
Tumors with TRK fusions (MSK, 2019): Tumors with TRK fusions based on MSK-IMPACT targeted sequencing.
- Description
This dataset contains summary data visualizations and clinical data from a broad sampling of tropomyosin receptor kinase (TRK) fusion tumors. The data was gathered utilizing the MSK-IMPACT targeted sequencing test. The clinical data includes tumor type (based on the opensource OncoTree ontology developed at MSK), information about mutated genes, patient demographics, and modality. The data set also...
- Subject
-
DNA Mutational AnalysisOncogene Proteins, FusionReceptor Protein-Tyrosine KinasesReceptor, trkAReceptor, trkBReceptor, trkC
- Access Rights
- Free to All
-
Myelodysplastic (MSKCC, 2020): Single-cell genomics reveals the genetic and molecular bases for escape from mutational epistasis in myeloid neoplasms
- Description
This dataset contains the summary data visualizations and clinical data from 4,231 myeloid neoplasm samples from 4,231 patients. Clinical data includes: Cancer Type, Cancer Type Detailed, Mutation Count, Oncotree Code, Sequencing Type, Somatic Status, Study. The plaintext components of the dataset can be downloaded as a tar file. The clinical data can be downloaded as a tsv file.
- Subject
-
Acute monoblastic/monocytic leukemiaAnemia, RefractoryAnemia, Refractory, with Excess of BlastsAnemia, SideroblasticLeukemia, Erythroblastic, AcuteLeukemia, Megakaryoblastic, AcuteLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLeukemia, Myeloid, AcuteLeukemia, Myelomonocytic, AcuteLeukemia, Myelomonocytic, ChronicMastocytosisMyelodysplastic SyndromesMyelodysplastic-Myeloproliferative DiseasesOncogene Proteins, FusionPolycythemia VeraPrimary MyelofibrosisSarcoma, MyeloidThrombocythemia, Essential
- Access Rights
- Free to All
- Local Expert
- Papaemmanuil, Elli
-
33 patients with Monoclonal Gammopathy of Undetermined Significance (MGUS)
- Description
Dataset Description from EGA: " Monoclonal gammopathy of undetermined significance (MGUS) is a premalignant precursor of multiple myeloma (MM) with a 1% risk of progression per year. Although targeted analyses have shown the presence of specific genetic abnormalities such as IGH translocations, RB1 deletion, 1q gain, hyperdiploidy or RAS genes mutations, little is known about molecular mechanism of...
- Subject
-
Monoclonal Gammopathy of Undetermined SignificanceMultiple MyelomaOncogene Proteins, Fusion
- Access Rights
- Application Required
-
Distinct mechanisms for TMPRSS2 expression explain organ-specific inhibition of SARS-CoV-2 infection by enzalutamide [ChIP-Seq]
- Authors
- Li, Fei
- Description
Summary from the GEO: "The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has rapidly become a global public health threat due to the lack of effective drugs or vaccines against SARS-CoV-2. The efficacy of several repurposed drugs has been evaluated in clinical trials. Among these drugs, a second second-generation antiandrogen...
- Subject
-
COVID-19Lung NeoplasmsOncogene Proteins, FusionProstatic Neoplasms
- Access Rights
- Free to All
-
Distinct mechanisms for TMPRSS2 expression explain organ-specific inhibition of SARS-CoV-2 infection by enzalutamide [ATAC-Seq]
- Authors
- Li, Fei
- Description
Summary from the GEO: "The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has rapidly become a global public health threat due to the lack of effective drugs or vaccines against SARS-CoV-2. The efficacy of several repurposed drugs has been evaluated in clinical trials. Among these drugs, a second second-generation antiandrogen...
- Subject
-
COVID-19Lung NeoplasmsOncogene Proteins, FusionProstatic Neoplasms
- Access Rights
- Free to All
-
UAMS Smoldering Myeloma Timeline Cohort
- Description
Dataset Description from the EGA: "To better understand the pattern of genetic changes over time, we performed whole exome sequencing of sequential bone marrow samples from 9 patients taken overtime including some paired SMM/newly diagnosed MM/Relapse MM samples. Samples from 9 patients (9 controls and 53 tumors) underwent whole exome sequencing with an additional capture for the IGH, IHK, IGL, and...
- Subject
-
Multiple MyelomaNeoplasms, Plasma CellOncogene Proteins, FusionSmoldering Multiple Myeloma
- Access Rights
- Application Required